A study with IMO-8400 in Patients with Moderate to Severe Psoriasis

Update Il y a 4 ans
Reference: EUCTR2013-000164-28

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Evaluation of safety and tolerability of different dose levels of IMO-8400 compared with placebo administered for 12 weeks


Inclusion criteria

  • Moderate to Severe Plaque Psoriasis

Links